Acadian Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,025
| Closed | -$52K | – | 2304 |
|
2021
Q1 | $52K | Buy |
2,025
+997
| +97% | +$25.6K | ﹤0.01% | 1816 |
|
2020
Q4 | $23K | Buy |
+1,028
| New | +$23K | ﹤0.01% | 2131 |
|
2020
Q1 | – | Sell |
-4,334
| Closed | -$95K | – | 2002 |
|
2019
Q4 | $95K | Buy |
+4,334
| New | +$95K | ﹤0.01% | 1476 |
|
2018
Q2 | – | Sell |
-23,566
| Closed | -$225K | – | 1906 |
|
2018
Q1 | $225K | Buy |
+23,566
| New | +$225K | ﹤0.01% | 1033 |
|
2017
Q2 | – | Sell |
-325
| Closed | -$1K | – | 1664 |
|
2017
Q1 | $1K | Buy |
+325
| New | +$1K | ﹤0.01% | 1531 |
|
2015
Q3 | – | Sell |
-964
| Closed | -$13K | – | 1483 |
|
2015
Q2 | $13K | Buy |
+964
| New | +$13K | ﹤0.01% | 1133 |
|